Webinar Overview

Recombinant technology has been receiving a lot of attention recently, but does that mean it’s ready for use in the QC lab? As we too are currently in the R&D phase of developing a recombinant LAL product, we recently collected water samples from global pharmaceutical organizations and performed testing on our products as well as a variety of LAL and recombinant products from multiple vendors. The results were revealing.

In this short webinar, we’ll examine:

  • The protocol used for establishing the study and full data results
  • The impact other factors within the LAL cascade provide to the binding of LPS and detection of endotoxins
  • Next steps in data generation

 

Webinar Presenter

John Dubczak
Executive Director of Reagent Development and Pilot Plant Operations, Charles River